Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Molecular Cancer Therapeutics|January 14, 2009
Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancerAnna Martinez-Cardús, Eva Martinez-Balibrea, Eva Bandrés, et al.
British Journal of Anaesthesia|December 18, 2025
The Air-Test score for prediction of postoperative pulmonary complications after general anaesthesia: analysis of harmonised trial data and a prospective observational cohortRamsés Marrero, Jordi Vallverdú, Miguel Linares, et al.
Clinical Colorectal Cancer|September 10, 2013
Prognostic value of the combination of circulating tumor cells plus KRAS in patients with metastatic colorectal cancer treated with chemotherapy plus bevacizumabJavier Sastre, Marta Vidaurreta, Auxiliadora Gómez, et al.
Plos One|May 9, 2015
PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell LinesAlba Ginés, Sara Bystrup, Vicenç Ruiz de Porras, et al.
Investigational New Drugs|October 31, 2003
Weekly regimen of irinotecan/docetaxel in previously treated non-small cell lung cancer patients and correlation with uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphismAlbert Font, José Miguel Sánchez, Miquel Tarón, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 23, 2011
Treatment recommendations for metastatic colorectal cancerEnrique Aranda, Albert Abad, Alfredo Carrato, et al.
Molecular Cancer Therapeutics|July 18, 2015
Tumor-Related Molecular Mechanisms of Oxaliplatin ResistanceEva Martinez-Balibrea, Anna Martínez-Cardús, Alba Ginés, et al.
Journal of Applied Clinical Medical Physics|February 23, 2024
International collaboration between low-middle-income and high-income institutions to improve radiation therapy care deliveryDiana Ng, Tatiana De Martin, Po Ting Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Irinotecan in combination with fluorouracil in a 48-hour continuous infusion as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors studyJavier Sastre, Eugenio Marcuello, Bartomeu Masutti, et al.
Clinical Colorectal Cancer|April 6, 2005
Two consecutive phase II trials of biweekly oxaliplatin plus weekly 48-hour continuous infusion of nonmodulated high-dose 5-fluorouracil as first-line treatment for advanced colorectal cancerAlbert Abad, Alfredo Carrato, Matilde Navarro, et al.
Pageof 4